Abstract:
A mobile gateway device collects identities of a first set of radio nodes which are within one hop of the mobile gateway; and checks at least the collected identities against a first table and a second table. The first table lists node identities and corresponding data validity timers. The second table lists node identities and no corresponding data validity timers. From the checking the device selects a group of radio nodes to activate for collecting and reporting data. The device determines parent child relations among the radio nodes, which are sensor nodes of a wireless sensing network in an embodiment, and uses the list to activate only those nodes for which it does not have valid data to sense new data and transmit their sensing results.
Abstract:
A direct oxidation fuel cell system includes a membrane electrode assembly (MEA), a high concentration fuel and an oxidant source. Embodiments include a controller for adjusting the oxidant stoichiometric ratio or air flow to maximize the liquid water phase in the cathode exhaust and minimize the water vapor in the exhaust thereby eliminating the need for a water condenser for condensing water vapor produced and exhausted from the cathode of the MEA.
Abstract:
The present invention is directed to N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-s-oxo-1(2H)-pyrazineacetamide, pharmaceutical compositions containing said compound and methods of treatment comprising inhibiting a serine protease using said compound. The present invention is further directed to a process for the preparation of the N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2H)-pyrazineacetamide as a free base. The present invention is further directed to a process for the preparation of pharmaceutically acceptable salts of N-[2-[[(aminoiminomethyl)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2H)-pyrazineacetamide.